BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36377878)

  • 41. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli.
    Simionatto S; Marchioro SB; Galli V; Hartwig DD; Carlessi RM; Munari FM; Laurino JP; Conceição FR; Dellagostin OA
    Protein Expr Purif; 2010 Feb; 69(2):132-6. PubMed ID: 19747547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins.
    Simionatto S; Marchioro SB; Galli V; Brum CB; Klein CS; Rebelatto R; Silva EF; Borsuk S; Conceição FR; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2012 Mar; 35(2):209-16. PubMed ID: 22304900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.
    Fagan PK; Walker MJ; Chin J; Eamens GJ; Djordjevic SP
    Microb Pathog; 2001 Feb; 30(2):101-10. PubMed ID: 11162190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control.
    Maes D; Sibila M; Kuhnert P; Segalés J; Haesebrouck F; Pieters M
    Transbound Emerg Dis; 2018 May; 65 Suppl 1():110-124. PubMed ID: 28834294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic Variability and Post-translational Protein Processing Enhance the Immune Evasion of
    Li G; Obeng E; Shu J; Shu J; Chen J; Wu Y; He Y
    Front Immunol; 2020; 11():510943. PubMed ID: 33117335
    [No Abstract]   [Full Text] [Related]  

  • 47. Different local, innate and adaptive immune responses are induced by two commercial
    Beuckelaere L; Haspeslagh M; Biebaut E; Boyen F; Haesebrouck F; Krejci R; Meyer E; Gleerup D; De Spiegelaere W; Devriendt B; Maes D
    Front Immunol; 2022; 13():1015525. PubMed ID: 36569943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation of Mycoplasma hyopneumoniae from Brazilian field samples.
    Assao VS; Scatamburlo TM; Araujo EN; Santos MR; Pereira CER; Guedes RMC; Bressan GC; Fietto JLR; Chang YF; Moreira MAS; Silva-Júnior A
    BMC Microbiol; 2019 Oct; 19(1):234. PubMed ID: 31660853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and
    Tao Y; Li G; Zheng W; Shu J; Chen J; Yang F; Wu Y; He Y
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505747
    [No Abstract]   [Full Text] [Related]  

  • 50. Chimeric proteins of Mycoplasma hyopneumoniae as vaccine and preclinical model for immunological evaluation.
    Santos MR; Toledo LT; Bassi ÊJ; Porto WJN; Bressan GC; Moreira MAS; Chang YF; Silva-Júnior A
    Braz J Microbiol; 2024 Mar; 55(1):943-953. PubMed ID: 38217795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
    Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
    Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systems Immunology Characterization of Novel Vaccine Formulations for
    Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
    Front Immunol; 2019; 10():1087. PubMed ID: 31178860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs.
    Shimoji Y; Oishi E; Kitajima T; Muneta Y; Shimizu S; Mori Y
    Infect Immun; 2002 Jan; 70(1):226-32. PubMed ID: 11748187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.
    Marchioro SB; Fisch A; Gomes CK; Jorge S; Galli V; Haesebrouck F; Maes D; Dellagostin O; Conceição FR
    Vet Microbiol; 2014 Sep; 173(1-2):166-71. PubMed ID: 25091529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
    Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
    BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of Mycoplasma hyopneumoniae-specific immunity in vaccinated pigs.
    Biebaut E; Beuckelaere L; Boyen F; Haesebrouck F; Gomez-Duran CO; Devriendt B; Maes D
    Vet Res; 2023 Mar; 54(1):16. PubMed ID: 36859402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective efficacy of a live attenuated Mycoplasma hyopneumoniae vaccine with an ISCOM-matrix adjuvant in pigs.
    Xiong Q; Wei Y; Feng Z; Gan Y; Liu Z; Liu M; Bai F; Shao G
    Vet J; 2014 Feb; 199(2):268-74. PubMed ID: 24314715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycoplasma hyopneumoniae: from disease to vaccine development.
    Simionatto S; Marchioro SB; Maes D; Dellagostin OA
    Vet Microbiol; 2013 Aug; 165(3-4):234-42. PubMed ID: 23680109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of bivalent vaccines of porcine circovirus type 2 and
    Lim J; Jin M; Yoon I; Yoo HS
    J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.